Lecanemab Favors Early Aggregates. Fluorescently labeled lecanemab (green) bound most strongly to soluble Aβ aggregates ...

One of the major components of these protein buildups was thought to be a protein called amyloid beta, or Aβ42, which clump together into what is known as amyloid plaques. However, a new study ...

Researchers determine the differential risk of dementia among men and women based on the presence of obstructive sleep apnea.

However, while the level of Aβ42 in blood is not by itself a good biomarker for AD, the Aβ42:Aβ40 ratio has gained attention as a plasma biomarker that predicts amyloid-PET status regardless of ...

On Tuesday, Coya Therapeutics, Inc. (NASDAQ:COYA) released results from the placebo-controlled Phase 2 trial of LD IL-2 in ...

The research identified elevated levels of amyloid-β 42 (Aβ42) protein in participants with higher caffeine intake. This protein serves as a crucial marker in Alzheimer’s progression ...

Four out of five measured biomarkers (p-tau217, Aβ40, Aβ42, and NfL) showed levels of fluctuation throughout the day. Only GFAP did not show a statistically significant variation. Currently, it is not ...

Chardan Capital analyst Keay Nakae reiterated a Buy rating on Coya Therapeutics, Inc. (COYA – Research Report) today and set a price ...

Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), has introduced LucentAD Complete, a new multi-marker ...

Coya (COY) stock tumbled 23% Tuesday on mixed results from a Phase 2 clinical trial of its therapy candidate LD IL-2 in the ...

Nov. 7, 2024 — Scientists have created a robot that can learn tasks like cleaning a washbasin just by watching humans. A special sponge with sensors is used to show the robot how to clean. Using ...